Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Multimodal data integration has emerged as a transformative approach in the health care sector, systematically combining complementary biological and clinical data sources such as genomics, medical imaging, electronic health records, and wearable device outputs. This approach provides a multidimensional perspective of patient health that enhances the diagnosis, treatment, and management of various medical conditions. This viewpoint presents an overview of the current state of multimodal integration in health care, spanning clinical applications, current challenges, and future directions. We focus primarily on its applications across different disease domains, particularly in oncology and ophthalmology. Other diseases are briefly discussed due to the few available literature. In oncology, the integration of multimodal data enables more precise tumor characterization and personalized treatment plans. Multimodal fusion demonstrates accurate prediction of anti-human epidermal growth factor receptor 2 therapy response (area under the curve=0.91). In ophthalmology, multimodal integration through the combination of genetic and imaging data facilitates the early diagnosis of retinal diseases. However, substantial challenges remain regarding data standardization, model deployment, and model interpretability. We also highlight the future directions of multimodal integration, including its expanded disease applications, such as neurological and otolaryngological diseases, and the trend toward large-scale multimodal models, which enhance accuracy. Overall, the innovative potential of multimodal integration is expected to further revolutionize the health care industry, providing more comprehensive and personalized solutions for disease management.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12370271PMC
http://dx.doi.org/10.2196/76557DOI Listing

Publication Analysis

Top Keywords

multimodal integration
20
health care
16
multimodal
9
integration health
8
applications disease
8
disease management
8
multimodal data
8
future directions
8
health
6
integration
6

Similar Publications

The global surge in the population of people 60 years and older, including that in China, challenges healthcare systems with rising age-related diseases. To address this demographic change, the Aging Biomarker Consortium (ABC) has launched the X-Age Project to develop a comprehensive aging evaluation system tailored to the Chinese population. Our goal is to identify robust biomarkers and construct composite aging clocks that capture biological age, defined as an individual's physiological and molecular state, across diverse Chinese cohorts.

View Article and Find Full Text PDF

Two birds with one stone: Versatile lanthanide-doped core-shell-shell nanoparticles with enhanced red upconversion for nanothermometry and MR imaging.

J Colloid Interface Sci

September 2025

Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu 610041, China. Electronic address: Zhaoy

Lanthanide-doped fluoride nanoparticles show great potential for optical thermometry and bioimaging. However, their applications are still constrained by inherent limitations in luminescence intensity and functional versatility. To overcome these challenges, we propose a core-active shell-inert shell nanostructure that integrates multifunctional capabilities within a single platform.

View Article and Find Full Text PDF

Artificial intelligence (AI) is transforming many fields, including healthcare and medicine. In biomarker discovery, AI algorithms have had a profound impact, thanks to their ability to derive insights from complex high-dimensional datasets and integrate multi-modal datatypes (such as omics, electronic health records, imaging or sensor and wearable data). However, despite the proliferation of AI-powered biomarkers, significant hurdles still remain in translating them to the clinic and driving adoption, including lack of population diversity, difficulties accessing harmonised data, costly and time-consuming clinical studies, evolving AI regulatory frameworks and absence of scalable diagnostic infrastructure.

View Article and Find Full Text PDF

Drug-target interaction (DTI) prediction is essential for the development of novel drugs and the repurposing of existing ones. However, when the features of drug and target are applied to biological networks, there is a lack of capturing the relational features of drug-target interactions. And the corresponding multimodal models mainly depend on shallow fusion strategies, which results in suboptimal performance when trying to capture complex interaction relationships.

View Article and Find Full Text PDF

Sleep is essential for maintaining human health and quality of life. Analyzing physiological signals during sleep is critical in assessing sleep quality and diagnosing sleep disorders. However, manual diagnoses by clinicians are time-intensive and subjective.

View Article and Find Full Text PDF